A recent study demonstrated that latency-competent cancer (LCC) cells from early-stage human lung and breast carcinoma can enter a quiescence state through the expression of the WNT inhibitor DKK1 and a broad downregulation of ULBP ligands for NK cells. Here, DKK1 is linked to breast carcinoma.